Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Ryan D. Cassaday, MD
Daniel J. DeAngelo, MD, PhD
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
A.J. Gelderblom, MD, PhD
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
Chelsea Cole, MD
All Sides of the Joint: Integrated TGCT Care Across Specialties
Michiel van de Sande, MD, PhD
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
Giuseppe Curigliano, MD, PhD
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
Komal Jhaveri, MD, FACP
The Future of Oral SERDs: Combination Strategies
Routes Reconsidered: A Case-Based Debate in SERD Selection
Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events
Spotlight on Europe: Adapting the Evidence
MOA: CDH6-Targeted Antibody-Drug Conjugates
Kathleen Moore, MD, MS
CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer
Joyce F. Liu, MD, MPH
Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making
James M. Cleary, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.